Literature DB >> 27524199

Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.

Jing Xue1, Michaele Manigrasso2, Matteo Scalabrin1, Vivek Rai3, Sergey Reverdatto1, David S Burz1, Daniele Fabris1, Ann Marie Schmidt2, Alexander Shekhtman4.   

Abstract

The weak oligomerization exhibited by many transmembrane receptors has a profound effect on signal transduction. The phenomenon is difficult to characterize structurally due to the large sizes of and transient interactions between monomers. The receptor for advanced glycation end products (RAGE), a signaling molecule central to the induction and perpetuation of inflammatory responses, is a weak constitutive oligomer. The RAGE domain interaction surfaces that mediate homo-dimerization were identified by combining segmental isotopic labeling of extracellular soluble RAGE (sRAGE) and nuclear magnetic resonance spectroscopy with chemical cross-linking and mass spectrometry. Molecular modeling suggests that two sRAGE monomers orient head to head forming an asymmetric dimer with the C termini directed toward the cell membrane. Ligand-induced association of RAGE homo-dimers on the cell surface increases the molecular dimension of the receptor, recruiting Diaphanous 1 (DIAPH1) and activating signaling pathways.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NMR spectroscopy; RAGE; cancer; diabetes; diaphanous 1; hybrid method of structure determination; inflammation; mass spectrometry; pattern recognition; receptor for advanced glycation end products; segmental labeling; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27524199      PMCID: PMC5014727          DOI: 10.1016/j.str.2016.06.021

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  67 in total

Review 1.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Authors:  Stephane Angers; Ali Salahpour; Michel Bouvier
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

Review 3.  Transmembrane signaling: the joy of aggregation.

Authors:  H Metzger
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

4.  Mapping protein-protein interactions by bioinformatics and cross-linking.

Authors:  Peter Friedhoff
Journal:  Anal Bioanal Chem       Date:  2005-01       Impact factor: 4.142

5.  Structure and activity of full-length formin mDia1.

Authors:  Sankar Maiti; Alphee Michelot; Christopher Gould; Laurent Blanchoin; Olga Sokolova; Bruce L Goode
Journal:  Cytoskeleton (Hoboken)       Date:  2012-06

6.  Structural basis for ligand recognition and activation of RAGE.

Authors:  Michael Koch; Seth Chitayat; Brian M Dattilo; Andre Schiefner; Joachim Diez; Walter J Chazin; Günter Fritz
Journal:  Structure       Date:  2010-10-13       Impact factor: 5.006

7.  Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.

Authors:  Marieke A D van Zoelen; Ann-Marie Schmidt; Sandrine Florquin; Joost C Meijers; Regina de Beer; Alex F de Vos; Peter P Nawroth; Angelika Bierhaus; Tom van der Poll
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

8.  Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.

Authors:  Barry I Hudson; Anastasia Z Kalea; Maria Del Mar Arriero; Evis Harja; Eric Boulanger; Vivette D'Agati; Ann Marie Schmidt
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

9.  Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.

Authors:  Laure Yatime; Gregers R Andersen
Journal:  FEBS J       Date:  2013-10-25       Impact factor: 5.542

10.  AccPbFRET: an ImageJ plugin for semi-automatic, fully corrected analysis of acceptor photobleaching FRET images.

Authors:  János Roszik; János Szöllosi; György Vereb
Journal:  BMC Bioinformatics       Date:  2008-08-19       Impact factor: 3.169

View more
  23 in total

Review 1.  The receptor for advanced glycation end products (RAGE) and DIAPH1: unique mechanisms and healing the wounded vascular system.

Authors:  Ravichandran Ramasamy; Richard A Friedman; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Expert Rev Proteomics       Date:  2019-01-13       Impact factor: 3.940

2.  Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice.

Authors:  Michaele B Manigrasso; Piul Rabbani; Lander Egaña-Gorroño; Nosirudeen Quadri; Laura Frye; Boyan Zhou; Sergey Reverdatto; Lisa S Ramirez; Stephen Dansereau; Jinhong Pan; Huilin Li; Vivette D D'Agati; Ravichandran Ramasamy; Robert J DeVita; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 17.956

3.  Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.

Authors:  M Scalabrin; S M Dixit; M M Makshood; C E Krzemien; Daniele Fabris
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

Review 4.  22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-09       Impact factor: 8.311

Review 5.  Glycation & the RAGE axis: targeting signal transduction through DIAPH1.

Authors:  Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Proteomics       Date:  2016-12-22       Impact factor: 3.940

6.  Development of novel nanofibers targeted to smoke-injured lungs.

Authors:  Alexandra I Mercel; Kathleen Marulanda; David C Gillis; Kui Sun; Tristan D Clemons; Smaranda Willcox; Jack Griffith; Erica B Peters; Mark R Karver; Nick D Tsihlis; Rob Maile; Samuel I Stupp; Melina R Kibbe
Journal:  Biomaterials       Date:  2021-04-29       Impact factor: 15.304

Review 7.  Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.

Authors:  Salvatore Bongarzone; Vilius Savickas; Federico Luzi; Antony D Gee
Journal:  J Med Chem       Date:  2017-05-19       Impact factor: 7.446

8.  Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice.

Authors:  Kathleen Marulanda; Alexandra Mercel; David C Gillis; Kui Sun; Maria Gambarian; Joshua Roark; Jenna Weiss; Nick D Tsihlis; Mark R Karver; S Ruben Centeno; Erica B Peters; Tristan D Clemons; Samuel I Stupp; Sean E McLean; Melina R Kibbe
Journal:  Adv Healthc Mater       Date:  2021-06-01       Impact factor: 11.092

Review 9.  RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy.

Authors:  Wioletta Olejarz; Dominika Łacheta; Alicja Głuszko; Ewa Migacz; Wojciech Kukwa; Mirosław J Szczepański; Piotr Tomaszewski; Grażyna Nowicka
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

10.  Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease.

Authors:  Laura Senatus; Michael MacLean; Lakshmi Arivazhagan; Lander Egaña-Gorroño; Raquel López-Díez; Michaele B Manigrasso; Henry H Ruiz; Carolina Vasquez; Robin Wilson; Alexander Shekhtman; Paul F Gugger; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Immunometabolism       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.